02487.HK
Cutia Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 1.76
+0.57%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 9.61x
- P/E 2028E
- 3.79x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.62x
- Price / sales
- 0.89x
- Price / cash flow
- -0.73x
Enterprise value
- Enterprise value
- HKD 91.6M
- EV / sales
- 0.13x
- EV / EBITDA
- -0.11x
- EV / EBIT
- -0.10x
- Market cap
- HKD 641.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025